Deborah Welsh, APRN
Adult Health · Paducah, KYNPI 1851631410
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 451 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,463 and has fallen 74.4% since, to $631 in 2025. Among adult health clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 451 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$640
- Acadia Pharmaceuticals Inc$381
- CSL Behring$374
- AstraZeneca$369
- Lundbeck LLC$303
- plus $4K from 33 others
What the payments were for
- Food & beverage$7,345100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$7,345 in reported general payments places this provider in the 90th percentile of 170 adult health providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 36 | $8,362 |
| Gabapentin | 48 | $765 |
| Pregabalin | 12 | $597 |
| Levetiracetam | 13 | $428 |
| Phenobarbital | 22 | $258 |
Paid to pharmacies, not to this prescriber.
Other adult health in Paducah
- Amy BakerPaducah$14K
- Jennifer ThomasPaducah$7K
- Tara LykinsPaducah$4K
- Linda DallPaducah$4K
- Anna StewartPaducah$1K
- Carrie Clifford-BennettGeorgetown$730K
- Stephanie FlaspoehlerLouisville$174K
- Kimberly VesselsBrandenburg$58K
- Heidi GalloLouisville$15K
- Joyce JohnsonElizabethtown$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.